Envestnet Asset Management Inc. Sells 75,705 Shares of STERIS plc (NYSE:STE)

Envestnet Asset Management Inc. cut its stake in STERIS plc (NYSE:STE) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 466,268 shares of the medical equipment provider’s stock after selling 75,705 shares during the period. Envestnet Asset Management Inc. owned 0.47% of STERIS worth $95,846,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of STE. Magnolia Capital Advisors LLC raised its holdings in STERIS by 1.9% during the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock worth $521,000 after purchasing an additional 48 shares during the last quarter. SkyView Investment Advisors LLC grew its position in shares of STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock worth $765,000 after buying an additional 51 shares during the period. Park Edge Advisors LLC raised its stake in shares of STERIS by 1.1% during the fourth quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock worth $958,000 after buying an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI lifted its holdings in STERIS by 5.9% in the fourth quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock valued at $201,000 after buying an additional 54 shares during the period. Finally, Opal Wealth Advisors LLC boosted its stake in STERIS by 5.7% in the fourth quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock valued at $230,000 after acquiring an additional 60 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have commented on STE shares. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Monday. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Stephens reaffirmed an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Stock Down 2.1 %

NYSE:STE opened at $208.26 on Wednesday. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The stock has a 50-day moving average price of $222.54 and a two-hundred day moving average price of $219.97. The stock has a market cap of $20.46 billion, a price-to-earnings ratio of 44.22 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.09%. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.